A Prospective Study of Nonmedical Use of Prescription Opioids During Adolescence and Subsequent Substance Use Disorder Symptoms in Early Midlife

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2018 Nov 28

PMID 30481692

Citations 38

Authors

Sean Esteban McCabe

Philip T Veliz

Carol J Boyd

Ty S Schepis

Vita V McCabe

John E Schulenberg

Affiliations

Soon will be listed here.

Abstract

Background: This longitudinal study assesses characteristics associated with adolescents' nonmedical use of prescription opioids (NMUPO) including: frequency, co-ingestion, motives, specific opioid type; sequence of initiation of medical use of prescription opioids and NMUPO in relationship to subsequent substance use disorder (SUD) symptoms.

Methods: Twenty-one independent national cohorts of U.S. high school seniors (n = 8,373) were surveyed and followed 17 years from adolescence to age 35.

Results: The majority of adolescents who engaged in NMUPO reported occasional/frequent NMUPO, non-pain relief motives for NMUPO, simultaneous co-ingestion involving NMUPO and other drugs, opioid analgesics with high misuse potential, and multiple types of opioid analgesics. Adolescents who reported NMUPO for pain relief, NMUPO involving opioid analgesics with high misuse potential, or multiple prescription opioids had significantly greater odds of SUD symptoms at age 35, relative to those who had no history of NMUPO during adolescence. In addition, medical use of prescription opioids after initiating NMUPO (or NMUPO only) during adolescence was associated with significantly greater odds of subsequent SUD symptoms at age 35 relative to those who reported the medical use of prescription opioids only or had no medical use or NMUPO during adolescence.

Conclusions: This is the first U.S. national prospective study to examine the relationships between adolescents' NMUPO characteristics and later SUD symptoms in early midlife. Several characteristics (frequency, co-ingestion, motives, opioid type, and medical/NMUPO initiation history) were identified that could be used to screen and detect high-risk youth for indicated interventions to reduce prescription opioid misuse and SUDs.

Citing Articles

Other Momentary Substance Behaviors as Predictors of College Students' Prescription Drug Misuse in Daily Life: An Exploratory Study.

Papp L, Kouros C Addict Res Theory. 2024; 32(3):178-185.

PMID: 39109167 PMC: 11299861. DOI: 10.1080/16066359.2023.2234289.

Age 19-30 Union Formation Trajectories across the Past 30 Years within the U.S.: Delineating Heterogeneity in Trajectories and its Historical and Sociodemographic Variation.

Jager J, Staff J, Espinoza P Res Hum Dev. 2024; 21(1):26-49.

PMID: 39036538 PMC: 11259017. DOI: 10.1080/15427609.2024.2366110.

Adolescent oral oxycodone self-administration disrupts neurobehavioral and neurocognitive development.

McLaurin K, Ott R, Mactutus C, Booze R Neuropharmacology. 2024; 258:110064.

PMID: 38981578 PMC: 11418068. DOI: 10.1016/j.neuropharm.2024.110064.

Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia.

Chen Y, Xenitidis A, Hoffmann P, Matthews L, Padmanabhan S, Aravindan L Expert Rev Clin Pharmacol. 2024; 17(5-6):455-465.

PMID: 38626303 PMC: 11116045. DOI: 10.1080/17512433.2024.2343915.

Characteristics of Alcohol, Marijuana, and Other Drug Use Among Persons Aged 13-18 Years Being Assessed for Substance Use Disorder Treatment - United States, 2014-2022.

Connolly S, Govoni T, Jiang X, Terranella A, Guy Jr G, Green J MMWR Morb Mortal Wkly Rep. 2024; 73(5):93-98.

PMID: 38329914 PMC: 10861205. DOI: 10.15585/mmwr.mm7305a1.

References

Muthen B . Psychometric evaluation of diagnostic criteria: application to a two-dimensional model of alcohol abuse and dependence. Drug Alcohol Depend. 1996; 41(2):101-12. DOI: 10.1016/0376-8716(96)01226-4. View

Harrison L, Hughes A . Introduction--the validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Res Monogr. 1997; 167:1-16. View

Compton W, Thomas Y, Stinson F, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5):566-76. DOI: 10.1001/archpsyc.64.5.566. View

Wagemaakers F, Hollingworth S, Kreijkamp-Kaspers S, Tee E, Leendertse A, Van Driel M . Opioid analgesic use in Australia and The Netherlands: a cross-country comparison. Int J Clin Pharm. 2017; 39(4):874-880. DOI: 10.1007/s11096-017-0492-9. View

Patrick M, Schulenberg J, OMalley P, Johnston L, Bachman J . Adolescents' reported reasons for alcohol and marijuana use as predictors of substance use and problems in adulthood. J Stud Alcohol Drugs. 2010; 72(1):106-16. PMC: 3001673. DOI: 10.15288/jsad.2011.72.106. View

Gilson A, Ryan K, Joranson D, Dahl J . A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004; 28(2):176-88. DOI: 10.1016/j.jpainsymman.2004.01.003. View

Nargiso J, Ballard E, Skeer M . A systematic review of risk and protective factors associated with nonmedical use of prescription drugs among youth in the United States: a social ecological perspective. J Stud Alcohol Drugs. 2014; 76(1):5-20. View

Merline A, Jager J, Schulenberg J . Adolescent risk factors for adult alcohol use and abuse: stability and change of predictive value across early and middle adulthood. Addiction. 2008; 103 Suppl 1:84-99. PMC: 2649657. DOI: 10.1111/j.1360-0443.2008.02178.x. View

Harford T, Muthen B . The dimensionality of alcohol abuse and dependence: a multivariate analysis of DSM-IV symptom items in the National Longitudinal Survey of Youth. J Stud Alcohol. 2001; 62(2):150-7. DOI: 10.15288/jsa.2001.62.150. View

10.

Compton W, Volkow N . Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83 Suppl 1:S4-7. DOI: 10.1016/j.drugalcdep.2005.10.020. View

11.

McCabe S, Boyd C, Young A . Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2006; 40(1):76-83. PMC: 1764616. DOI: 10.1016/j.jadohealth.2006.07.016. View

12.

Sandvik R, Selbaek G, Kirkevold O, Aarsland D, Husebo B . Analgesic prescribing patterns in Norwegian nursing homes from 2000 to 2011: trend analyses of four data samples. Age Ageing. 2016; 45(1):54-60. DOI: 10.1093/ageing/afv184. View

13.

Catalano R, White H, Fleming C, Haggerty K . Is nonmedical prescription opiate use a unique form of illicit drug use?. Addict Behav. 2010; 36(1-2):79-86. PMC: 2981660. DOI: 10.1016/j.addbeh.2010.08.028. View

14.

Joranson D, Ryan K, Gilson A, Dahl J . Trends in medical use and abuse of opioid analgesics. JAMA. 2001; 283(13):1710-4. DOI: 10.1001/jama.283.13.1710. View

15.

Schulenberg J, Patrick M, Kloska D, Maslowsky J, Maggs J, OMalley P . Substance Use Disorder in Early Midlife: A National Prospective Study on Health and Well-Being Correlates and Long-Term Predictors. Subst Abuse. 2016; 9(Suppl 1):41-57. PMC: 4881872. DOI: 10.4137/SART.S31437. View

16.

Atluri S, Sudarshan G, Manchikanti L . Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014; 17(2):E119-28. View

17.

McCabe S, Cranford J, Morales M, Young A . Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006; 67(4):529-37. PMC: 1761923. DOI: 10.15288/jsa.2006.67.529. View

18.

Hastie B, Gilson A, Maurer M, Cleary J . An examination of global and regional opioid consumption trends 1980-2011. J Pain Palliat Care Pharmacother. 2014; 28(3):259-75. DOI: 10.3109/15360288.2014.941132. View

19.

Compton W, Volkow N . Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2005; 81(2):103-7. DOI: 10.1016/j.drugalcdep.2005.05.009. View

20.

Novak S, Nemeth W, Lawson K . Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med. 2004; 5(1):59-65. DOI: 10.1111/j.1526-4637.2004.04001.x. View